Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation

Nutrition Reviews

Volumn 75, Issue 5, 2017, Pages 307-326

  Pérez Martínez, Pablo ^a,b   Mikhailidis, Dimitri P ^c   Athyros, Vasilios G ^d   Bullo, Mónica ^b,e   Couture, Patrick ^f   Covas, María I ^b,g,h   de Koning, Lawrence ⁱ   Delgado Lista, Javier ^a,b   Díaz López, Andrés ^b,e   Drevon, Christian A ^j   Estruch, Ramón ^k   Esposito, Katherine ^l   Fitó, Montserrat ^b,g   Garaulet, Marta ^m   Giugliano, Dario ^l   García Ríos, Antonio ^a,b   Katsiki, Niki ^d   Kolovou, Genovefa ⁿ   Lamarche, Benoît ^f   Maiorino, Maria Ida ^l   Mena Sánchez, Guillermo ^b,e   Muñoz Garach, Araceli ^b,o   Nikolic, Dragana ^p   Ordovás, José M ^q,r,s   Pérez Jiménez, Francisco ^a,b   Rizzo, Manfredi ^p   Salas Salvadó, Jordi ^b,e   Schrö der, Helmut ^g,t   Tinahones, Francisco J ^b,o   de la Torre, Rafael ^b,g   van Ommen, Ben ^u   Wopereis, Suzan ^u   Ros, Emilio ^b,v   López Miranda, José ^a,b   more..

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^e HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^f UNIVERSITÉ LAVAL   (Canada)

^g HOSPITAL DEL MAR   (Spain)

^h NUPROAS (Nutritional Project Assessment)   (Sweden)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j UNIVERSITY OF OSLO   (Norway)

^k UNIVERSITY OF BARCELONA   (Spain)

^l SECOND UNIVERSITY OF NAPLES   (Italy)

^m UNIVERSITY OF MURCIA   (Spain)

ⁿ ONASSIS CARDIAC SURGERY CENTER   (Greece)

^o HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^p UNIVERSITY OF PALERMO   (Italy)

^q TUFTS UNIVERSITY   (United States)

^r CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^s IMDEA FOOD INSTITUTE   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u Toegepast Natuurwetenschappelijk Onderzoek   (Netherlands)

^v HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Dietary pattern; Lifestyle; Metabolic syndrome; Panel recommendation

Indexed keywords

ALCOHOL; OLIVE OIL; SWEETENING AGENT; UNSATURATED FATTY ACID;

ALCOHOL CONSUMPTION; ARTICLE; CANDY; CEREAL; CHRONOBIOLOGY; DAIRY PRODUCT; ENERGY EXPENDITURE; FAT INTAKE; FISH; FRUIT; FUNCTIONAL FOOD; HUMAN; LEGUME; LIFESTYLE MODIFICATION; MEAT; MEDITERRANEAN DIET; METABOLIC SYNDROME X; NUT; PHYSICAL ACTIVITY; SMOKING; SMOKING CESSATION; SUGAR-SWEETENED BEVERAGE; VEGETABLE; VEGETARIAN DIET; WEIGHT CONTROL; WEIGHT REDUCTION; WINE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; LIFESTYLE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; LIFE STYLE; METABOLIC SYNDROME X;

EID: 85027132652     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nux014     Document Type: Article

References (266)

1. Minich DM, Bland JS. Dietary management of the metabolic syndrome beyond macronutrients. Nutr Rev. 2008;66:429-444
2. Abete I, Astrup A, Martinez JA, et al. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev. 2010;68:214-231
3. Keane D, Kelly S, Healy NP, et al. Diet and metabolic syndrome: an overview. Curr Vasc Pharmacol. 2013;11:842-857
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497
5. Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062
6. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005;48:1684-1699
7. Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia. 2010;53:600-605
8. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752
9. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645
10. Beltran-Sanchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013;62:697-703
11. Knott CS, Coombs N, Stamatakis E, et al. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ. 2015;350:h384
12. Corrao G, Rubbiati L, Bagnardi V, et al. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505-1523
13. Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, et al. Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study. PLoS One. 2014;9:e96406
14. Ellison RC, Zhang Y, Qureshi MM, et al. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2004;147:529-535
15. Schroder H, Morales-Molina JA, Bermejo S, et al. Relationship of abdominal obesity with alcohol consumption at population scale. Eur J Nutr. 2007;46:369-376
16. Whitfield JB, Heath AC, Madden PA, et al. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcohol Clin Exp Res. 2013;37:575-586
17. Taylor B, Irving HM, Baliunas D, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981-1990
18. Koppes LL, Dekker JM, Hendriks HF, et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care. 2005;28:719-725
19. Alkerwi A, Boutsen M, Vaillant M, et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis. 2009;204:624-635
20. Freiberg MS, Cabral HJ, Heeren TC, et al. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27:2954-2959
21. Barrio-Lopez MT, Bes-Rastrollo M, Sayon-Orea C, et al. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort. Clin Nutr. 2013;32:797-804
22. Tresserra-Rimbau A, Medina-Remon A, Lamuela-Raventos RM, et al. Moderate red wine consumption is associated with a lower prevalence of the metabolic syndrome in the PREDIMED population. Br J Nutr. 2015;113(suppl 2):S121-S130
23. Chiva-Blanch G, Urpi-Sarda M, Ros E, et al. Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. Clin Nutr. 2013;32:200-206
24. Chiva-Blanch G, Urpi-Sarda M, Ros E, et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res. 2012;111:1065-1068
25. Covas MI, Nyyssonen K, Poulsen HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med. 2006;145:333-341
26. Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979-2001. Diabetes Res Clin Pract. 2007;78:217-224
27. Fumeron F, Lamri A, Emery N, et al. Dairy products and the metabolic syndrome in a prospective study, DESIR. J Am Coll Nutr. 2011;30(5 suppl 1):454S-463S
28. Pfeuffer M, Auinger A, Bley U, et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis. 2013;23:403-409
29. Gepner Y, Golan R, Harman-Boehm I, et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial. Ann Intern Med. 2015;163:569-579
30. Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a metaanalysis of prospective studies. PLoS One. 2012;7:e47791
31. Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, et al. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med. 2013;11:195
32. Hwang GY, Cho YJ, Chung RH, Kim SH. The relationship between smoking level and metabolic syndrome in male health check-up examinees over 40 years of age. Korean J Fam Med. 2014;35:219-226
33. Berlin I, Lin S, Lima JA, et al. Smoking status and metabolic syndrome in the multi-ethnic study of atherosclerosis. A cross-sectional study. Tob Induc Dis. 2012;10:9
34. Carnethon MR, Loria CM, Hill JO, et al. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001 Diabetes Care. 2004;27:2707-2715
35. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;90:164-168
36. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391-397
37. Wakabayashi I. Associations of alcohol drinking and cigarette smoking with serum lipid levels in healthy middle-aged men. Alcohol Alcohol. 2008;43:274-280
38. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007;46:1079-1082
39. CaloWA, Ortiz AP, Suarez E, et al. Association of cigarette smoking and metabolic syndrome in a Puerto Rican adult population. J Immigr Minor Health. 2013;15:810-816
40. Kim BJ, Kim BS, Sung KC, et al. Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study. Diabetes Care. 2009;32:1314-1316
41. de Oliveira Fontes Gasperin L, Neuberger M, Tichy A, et al. Cross-sectional association between cigarette smoking and abdominal obesity among Austrian bank employees. BMJ Open. 2014;4:e004899
42. Pan A, Wang Y, Talaei M, et al. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:958-967
43. Sattar N, Sorensen T, Taylor AE, et al. Smoking and diabetes risk: building a causal case with clinical implications. Lancet Diabetes Endocrinol. 2015;3:918-920
44. Tian J, Venn A, Otahal P, et al. The association between quitting smoking and weight gain: a systemic review and meta-analysis of prospective cohort studies. Obes Rev. 2015;16:883-901
45. Aubin HJ, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439
46. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks 2009. Geneva, Switzerland: WHO Press; 2009
47. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ. 2006;174:801-809
48. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039-1049
49. Janiszewski PM, Ross R. The utility of physical activity in the management of global cardiometabolic risk. Obesity (Silver Spring). 2009;17(suppl 3):S3-S14
50. Misra A, Alappan NK, Vikram NK, et al. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes. Diabetes Care. 2008;31:1282-1287
51. Ilanne-Parikka P, Laaksonen DE, Eriksson JG, et al. Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. Diabetes Care. 2010;33:1610-1617
52. He D, Xi B, Xue J, et al. Association between leisure time physical activity and metabolic syndrome: a meta-analysis of prospective cohort studies. Endocrine. 2014;46:231-240
53. Conceicao MS, Bonganha V, Vechin FC, et al. Sixteen weeks of resistance training can decrease the risk of metabolic syndrome in healthy postmenopausal women. Clin Interv Aging. 2013;8:1221-1228
54. Ekelund U, Ward HA, Norat T, et al. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC). Am J Clin Nutr. 2015;101:613-621
55. Aadahl M, Kjaer M, Jorgensen T. Influence of time spent on TV viewing and vigorous intensity physical activity on cardiovascular biomarkers. The Inter 99 study. Eur J Cardiovasc Prev Rehabil. 2007;14:660-665
56. Thorp AA, Healy GN, Owen N, et al. Deleterious associations of sitting time and television viewing time with cardiometabolic risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004-2005. Diabetes Care. 2010;33:327-334
57. Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-170
58. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. 2008. http://www.health.gov/PAGuidelines. Accessed October 26, 2016
59. Li Y, Lee S, Langleite T, et al. Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention. Physiol Rep. 2014;2:e12187
60. Katsiki N, Athyros VG, Karagiannis A, et al. Metabolic syndrome and non-cardiac vascular diseases: an update from human studies. Curr Pharm Des. 2014;20:4944-4952
61. Teixeira TF, Alves RD, Moreira AP, et al. Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev. 2015;73:175-190
62. Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31-42
63. Katsiki N, Athyros VG, Karagiannis A, et al. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol. 2014;12:627-641
64. Lioudaki E, Vrentzos GE, Mavrogeni H, et al. Prevalence of metabolic syndrome according to different definitions in a hypertensive population. Angiology. 2012;63:39-47
65. Athyros VG, Ganotakis ES, Tziomalos K, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010;26:713-719
66. Tobias DK, Chen M, Manson JE, et al. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:968-979
67. Steffen LM, Van Horn L, Daviglus ML, et al. A modified Mediterranean diet score is associated with a lower risk of incident metabolic syndrome over 25 years among young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Br J Nutr. 2014;112:1654-1661
68. Pucci A, Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol. 2015;31:142-152
69. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934
70. Valenta I, Dilsizian V, Quercioli A, et al. Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. Curr Cardiol Rep. 2014;16:433
71. Athyros VG, Ganotakis E, Kolovou GD, et al. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospectiverandomized study in middle aged men and women. Curr Vasc Pharmacol. 2011;9:647-657
72. Bach-Faig A, Berry EM, Lairon D, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14(12A):2274-2284
73. Martinez-Gonzalez MA, Salas-Salvado J, Estruch R, et al. Benefits of the Mediterranean diet: insights from the PREDIMED Study. Prog Cardiovasc Dis. 2015;58:50-60
74. Mozaffarian D, Ludwig DS. The 2015 US Dietary Guidelines: lifting the ban on total dietary fat. JAMA. 2015;313:2421-2422
75. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction andmarkers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292:1440-1446
76. Babio N, Toledo E, Estruch R, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ. 2014;186:E649-657
77. Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, et al. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care. 2007;30:2957-2959
78. Meydani M. A Mediterranean-style diet and metabolic syndrome. Nutr Rev. 2005;63:312-314
79. Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534, 906 individuals. J Am Coll Cardiol. 2011;57:1299-1313
80. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, et al. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des. 2011;17:769-777
81. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes. 2014;7:95-105
82. Esposito K, Ceriello A, Giugliano D. Diet and the metabolic syndrome. Metab Syndr Relat Disord. 2007;5:291-296
83. Esposito K, Ciotola M, Maiorino MI, et al. Lifestyle approach for type 2 diabetes and metabolic syndrome. Curr Atheroscler Rep. 2008;10:523-528
84. Salas-Salvado J, Fernandez-Ballart J, Ros E, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med. 2008;168:2449-2458
85. Covas MI, de la Torre R, Fito M. Virgin olive oil: a key food for cardiovascular risk protection. Br J Nutr. 2015;113(suppl 2):S19-S28
86. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010;29(suppl 3):289S-301S
87. Gillingham LG, Harris-Janz S, Jones PJ. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids. 2011;46:209-228
88. Lopez-Miranda J, Perez-Jimenez F, Ros E, et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis. 2010;20:284-294
89. Ferrara LA, Raimondi AS, d'Episcopo L, et al. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000;160:837-842
90. Bondia-Pons I, Schroder H, Covas MI, et al. Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. J Nutr. 2007;137:84-87
91. Nigam P, Bhatt S, Misra A, et al. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease. Diabetes Technol Ther. 2014;16:255-261
92. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438
93. Yubero-Serrano EM, Delgado-Lista J, Pena-Orihuela P, et al. Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med. 2013;45:e28
94. Lapointe A, Couillard C, Lemieux S. Effects of dietary factors on oxidation of lowdensity lipoprotein particles. J Nutr Biochem. 2006;17:645-658
95. Sola R, La Ville AE, Richard JL, et al. Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med. 1997;22:1037-1045
96. Covas MI. Olive oil and the cardiovascular system. Pharmacol Res. 2007;55:175-186
97. van Dijk SJ, Feskens EJ, Bos MB, et al. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr. 2009;90:1656-1664
98. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, et al. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis. 2009;204:e70-76
99. Cabello-Moruno R, Perona JS, Ruiz-Gutierrez V. Influence of minor components of olive oils on the composition and size of TRLs and on macrophage receptors involved in foam cell formation. Biochem Soc Trans. 2007;35(pt 3):470-471
100. Hernaez A, Fernandez-Castillejo S, Farras M, et al. Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial. Arterioscler Thromb Vasc Biol. 2014;34:2115-2119
101. Covas MI, de la Torre K, Farre-Albaladejo M, et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med. 2006;40:608-616
102. Konstantinidou V, Covas MI, Sola R, et al. Up-to date knowledge on the in vivo transcriptomic effect of the Mediterranean diet in humans. Mol Nutr Food Res. 2013;57:772-783
103. Farras M, Valls RM, Fernandez-Castillejo S, et al. Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial. J Nutr Biochem. 2013;24:1334-1339
104. US. Food and Drug Administration. Press Release P04-100. November 1, 2004. http://www.fda.gov/bbs/topics/news/2004/NEW01129.htlm. Accessed October 26, 2016
105. European Union Commission; 2001. Council Regulation (EC) No. 1513/2001 of 23 July 2001 amending regulation (EC) 136/66/EEC and No. 1638/98 as regards the extension of the period of validity of the aid scheme and the quality strategy for olive oil. Off J Eur Comm. 2005;L201:4-7
106. Fito M, Guxens M, Corella D, et al. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med. 2007;167:1195-1203
107. Castaner O, Covas MI, Khymenets O, et al. Protection of LDL from oxidation by olive oil polyphenols is associated with a downregulation of CD40-ligand expression and its downstream products in vivo in humans. Am J Clin Nutr. 2012;95:1238-1244
108. US Department of Health and Human Services, US Department of Agriculture. 2015-2020 Dietary Guidelines for Americans. 8th ed. December 2015. http://health.gov/dietaryguidelines/2015/guidelines/. Accessed October 26, 2016
109. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007;85:910-918
110. Hsiao PY, Mitchell DC, Coffman DL, et al. Dietary patterns and relationship to obesity-related health outcomes and mortality in adults 75 years of age or greater. J Nutr Health Aging. 2013;17:566-572
111. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation. 2008;117:754-761
112. Azadbakht L, Mirmiran P, Esmaillzadeh A, et al. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28:2823-2831
113. Root MM, Dawson HR. DASH-like diets high in protein or monounsaturated fats improve metabolic syndrome and calculated vascular risk. Int J Vitam Nutr Res. 2013;83:224-231
114. Saneei P, Fallahi E, Barak F, et al. Adherence to the DASH diet and prevalence of the metabolic syndrome among Iranian women. Eur J Nutr. 2015;54:421-428
115. Saneei P, Hashemipour M, Kelishadi R, et al. Effects of recommendations to follow the Dietary Approaches to Stop Hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomised cross-over clinical trial. Br J Nutr. 2013;110:2250-2259
116. Uusitupa M, Hermansen K, Savolainen MJ, et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome-a randomized study (SYSDIET). J Intern Med. 2013;274:52-66
117. Rizzo NS, Sabate J, Jaceldo-Siegl K, et al. Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the Adventist Health Study 2. Diabetes Care. 2011;34:1225-1227
118. Turner-McGrievy G, Harris M. Key elements of plant-based diets associated with reduced risk of metabolic syndrome. Curr Diab Rep. 2014;14:524
119. Calton EK, James AP, Pannu PK, et al. Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence. Nutr Res. 2014;34:559-568
120. Sievenpiper JL, Kendall CW, Esfahani A, et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009;52:1479-1495
121. Sajjadi F, Gharipour M, Mohammadifard N, et al. Relationship between legumes consumption and metabolic syndrome: findings of the Isfahan Healthy Heart Program. ARYA Atheroscler. 2014;10:18-24
122. Mattei J, Hu FB, Campos H. A higher ratio of beans to white rice is associated with lower cardiometabolic risk factors in Costa Rican adults. Am J Clin Nutr. 2011;94:869-876
123. Papanikolaou Y, Fulgoni VL 3rd. Bean consumption is associated with greater nutrient intake, reduced systolic blood pressure, lower body weight, and a smaller waist circumference in adults: results from the National Health and Nutrition Examination Survey 1999-2002. J Am Coll Nutr. 2008;27:569-576
124. Hosseinpour-Niazi S, Mirmiran P, Mirzaei S, et al. Cereal, fruit and vegetable fibre intake and the risk of the metabolic syndrome: a prospective study in the Tehran Lipid and Glucose Study. J Hum Nutr Diet. 2015;28:236-245
125. Venn BJ, Mann JI. Cereal grains, legumes and diabetes. Eur J Clin Nutr. 2004;58:1443-1461
126. Murtaugh MA, Jacobs DR Jr, Jacob B, et al. Epidemiological support for the protection of whole grains against diabetes. Proc Nutr Soc. 2003;62:143-149
127. Villegas R, Gao YT, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008;87:162-167
128. Bazzano LA, Thompson AM, Tees MT, et al. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2011;21:94-103
129. Anderson JW, Major AW. Pulses and lipaemia, short-and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr. 2002;88(suppl 3):S263-S271
130. Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens. 2014;27:56-64
131. Sala-Vila A, Estruch R, Ros E. New insights into the role of nutrition in CVD prevention. Curr Cardiol Rep. 2015;17:26
132. Streppel MT, Arends LR, van 't Veer P, et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150-156
133. Hosseinpour-Niazi S, Mirmiran P, Sohrab G, et al. Inverse association between fruit, legume, and cereal fiber and the risk of metabolic syndrome: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2011;94:276-283
134. Williams PG. The benefits of breakfast cereal consumption: a systematic review of the evidence base. Adv Nutr. 2014;5:636S-673S
135. Kochar J, Gaziano JM, Djousse L. Breakfast cereals and risk of hypertension in the Physicians' Health Study I. Clin Nutr. 2012;31:89-92
136. Cooper AJ, Forouhi NG, Ye Z, et al. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr. 2012;66:1082-1092
137. Carter P, Gray LJ, Troughton J, et al. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;341:c4229
138. Shin JY, Kim JY, Kang HT, et al. Effect of fruits and vegetables on metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Int J Food Sci Nutr. 2015;66:416-425
139. Wallace IR, McEvoy CT, Hunter SJ, et al. Dose-response effect of fruit and vegetables on insulin resistance in people at high risk of cardiovascular disease: a randomized controlled trial. Diabetes Care. 2013;36:3888-3896
140. McCall DO, McGartland CP, McKinley MC, et al. The effect of increased dietary fruit and vegetable consumption on endothelial activation, inflammation and oxidative stress in hypertensive volunteers. Nutr Metab Cardiovasc Dis. 2011;21:658-664
141. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047-2067
142. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review andmeta-analysis. JAMA. 2012;308:1024-1033
143. Abete I, Goyenechea E, Zulet MA, et al. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011;21(suppl 2):B1-B15
144. Panagiotakos DB, Pitsavos C, Skoumas Y, et al. The association between food patterns and the metabolic syndrome using principal components analysis: the ATTICA Study. J Am Diet Assoc. 2007;107:979-987; quiz 997
145. Kim J, Jo I. Grains, vegetables, and fish dietary pattern is inversely associated with the risk of metabolic syndrome in South Korean adults. J Am Diet Assoc. 2011;111:1141-1149
146. Williams DE, Prevost AT, Whichelow MJ, et al. A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr. 2000;83:257-266
147. Puglisi MJ, Hasty AH, Saraswathi V. The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem. 2011;22:101-108
148. Ruidavets JB, Bongard V, Dallongeville J, et al. High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome. J Epidemiol Community Health. 2007;61:810-817
149. Baik I, Abbott RD, Curb JD, et al. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc. 2010;110:1018-1026
150. Noel SE, Newby PK, Ordovas JM, et al. Adherence to an (n-3) fatty acid/fish intake pattern is inversely associated with metabolic syndrome among Puerto Rican adults in the Greater Boston area. J Nutr. 2010;140:1846-1854
151. Erkkila AT, Schwab US, de Mello VD, et al. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr. 2008;47:319-328
152. Vazquez C, Botella-Carretero JI, Corella D, et al. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial. Nutr Metab Cardiovasc Dis. 2014;24:328-335
153. Lankinen M, Schwab U, Erkkila A, et al. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS One. 2009;4:e5258
154. Lankinen M, Schwab U, Kolehmainen M, et al. Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One. 2011;6:e22646
155. Slivkoff-Clark KM, James AP, Mamo JC. The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men. Nutr Metab (Lond). 2012;9:9
156. Balfego M, Canivell S, Hanzu FA, et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naive patients with type 2 diabetes: a pilot randomized trial. Lipids Health Dis. 2016;15:78
157. Lankinen M, Kolehmainen M, Jaaskelainen T, et al. Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet). PLoS One. 2014;9:e90352
158. Soares de Oliveira Carvalho AP, Kimi Uehara S, Nogueria Netto JF, et al. Hypocaloric diet associated with the consumption of jam enriched with microencapsulated fish oil decreases insulin resistance. Nutr Hosp. 2014;29:1103-1108
159. Lee TC, Ivester P, Hester AG, et al. The impact of polyunsaturated fatty acidbased dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population. Lipids Health Dis. 2014;13:196
160. Simao AN, Lozovoy MA, Bahls LD, et al. Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide. Br J Nutr. 2012;108:1435-1442
161. Dewell A, Marvasti FF, Harris WS, et al. Low-and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr. 2011;141:2166-2171
162. Root M, Collier SR, Zwetsloot KA, et al. A randomized trial of fish oil omega-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a young healthy population. Nutr J. 2013;12:40
163. Lai YH, Petrone AB, Pankow JS, et al. Association of dietary omega-3 fatty acids with prevalence of metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr. 2013;32:966-969
164. Poudyal H, Panchal SK, Diwan V, et al. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372-387
165. Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, et al. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2011;21(suppl 2):B32-B48
166. Ros E, Hu FB. Consumption of plant seeds and cardiovascular health: epidemiological and clinical trial evidence. Circulation. 2013;128:553-565
167. Afshin A, Micha R, Khatibzadeh S, et al. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:278-288
168. Zhou D, Yu H, He F, et al. Nut consumption in relation to cardiovascular disease risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2014;100:270-277
169. Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821-827
170. Flores-Mateo G, Rojas-Rueda D, Basora J, et al. Nut intake and adiposity: metaanalysis of clinical trials. Am J Clin Nutr. 2013;97:1346-1355
171. Blanco Mejia S, Kendall CW, Viguiliouk E, et al. Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2014;4:e004660
172. Ibarrola-Jurado N, Bullo M, Guasch-Ferre M, et al. Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study. PLoS One. 2013;8:e57367
173. Fernandez-Montero A, Bes-Rastrollo M, Beunza JJ, et al. Nut consumption and incidence of metabolic syndrome after 6-year follow-up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow-up) cohort. Public Health Nutr. 2013;16:2064-2072
174. O'Neil CE, Keast DR, Nicklas TA, et al. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999-2004. J Am Coll Nutr. 2011;30:502-510
175. Crichton GE, Bryan J, Buckley J, et al. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev. 2011;12:e190-201
176. Shin H, Yoon YS, Lee Y, et al. Dairy product intake is inversely associated with metabolic syndrome in Korean adults: Anseong and Ansan cohort of the Korean Genome and Epidemiology Study. J Korean Med Sci. 2013;28:1482-1488
177. Fumeron F, Lamri A, Abi Khalil C, et al. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2011;34:813-817
178. Drehmer M, Pereira MA, Schmidt MI, et al. Total and full-fat, but not low-fat, dairy product intakes are inversely associated with metabolic syndrome in adults. J Nutr. 2016;146:81-89
179. Babio N, Becerra-Tomas N, Martinez-Gonzalez MA, et al. Consumption of yogurt, low-fat milk, and other low-fat dairy products is associated with lower risk of metabolic syndrome incidence in an elderly Mediterranean population. J Nutr. 2015;145:2308-2316
180. Louie JC, Flood VM, Rangan AM, et al. Higher regular fat dairy consumption is associated with lower incidence of metabolic syndrome but not type 2 diabetes. Nutr Metab Cardiovasc Dis. 2013;23:816-821
181. Pereira MA, Jacobs DR Jr, Van Horn L, et al. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002;287:2081-2089
182. Kim Y, Je Y. Dairy consumption and risk of metabolic syndrome: a meta-analysis. Diabet Med. 2016;33:428-440
183. Tong X, Dong JY, Wu ZW, et al. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr. 2011;65:1027-1031
184. Aune D, Norat T, Romundstad P, et al. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013;98:1066-1083
185. Gao D, Ning N, Wang C, et al. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One. 2013;8:e73965
186. Chen M, Sun Q, Giovannucci E, et al. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 2014;12:215
187. Elwood PC, Pickering JE, Givens DI, et al. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010;45:925-939
188. Gijsbers L, Ding EL, Malik VS, et al. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr. 2016;103:1111-1124
189. O'Connor LM, Lentjes MA, Luben RN, et al. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia. 2014;57:909-917
190. Diaz-Lopez A, Bullo M, Martinez-Gonzalez MA, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr. 2016;55:349-360
191. Hirahatake KM, Slavin JL, Maki KC, et al. Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions. Metabolism. 2014;63:618-627
192. Shin JY, Xun P, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:146-159
193. Kurotani K, Nanri A, Goto A, et al. Cholesterol and egg intakes and the risk of type 2 diabetes: the Japan Public Health Center-based Prospective Study. Br J Nutr. 2014;112:1636-1643
194. Virtanen JK, Mursu J, Tuomainen TP, et al. Egg consumption and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2015;101:1088-1096
195. Louie JC, Flood VM, Hector DJ, et al. Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev. 2011;12:e582-592
196. Martinez-Gonzalez MA, Sayon-Orea C, Ruiz-Canela M, et al. Yogurt consumption, weight change and risk of overweight/obesity: the SUN cohort study. Nutr Metab Cardiovasc Dis. 2014;24:1189-1196
197. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-2404
198. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, et al. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond). 2012;36:1485-1493
199. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;96:735-747
200. Ralston RA, Lee JH, Truby H, et al. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Hum Hypertens. 2012;26:3-13
201. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev. 2007;8:109-118
202. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr. 2007;137(3 suppl 2):825S-829S
203. van Meijl LE, Vrolix R, Mensink RP. Dairy product consumption and the metabolic syndrome. Nutr Res Rev. 2008;21:148-157
204. Christensen R, Lorenzen JK, Svith CR, et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev. 2009;10:475-486
205. Zemel MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr. 2001;20(5 suppl):428S-435S; discussion 440S-442S
206. Astrup A, Chaput JP, Gilbert JA, et al. Dairy beverages and energy balance. Physiol Behav. 2010;100:67-75
207. Lorenzen J, Frederiksen R, Hoppe C, et al. The effect of milk proteins on appetite regulation and diet-induced thermogenesis. Eur J Clin Nutr. 2012;66:622-627
208. Lawrence GD. Dietary fats and health: dietary recommendations in the context of scientific evidence. Adv Nutr. 2013;4:294-302
209. World Health Organization. Guideline: Sugars Intake for Adult and Children. Geneva: World Health Organization; 2015
210. Popkin BM, Nielsen SJ. The sweetening of the world's diet. Obes Res. 2003;11:1325-1332
211. Laville M, Nazare JA. Diabetes, insulin resistance and sugars. Obes Rev. 2009;10(suppl 1):24-33
212. Singh GM, Micha R, Khatibzadeh S, et al. Global, regional, and national consumption of sugar-sweetened beverages, fruit juices, and milk: a systematic assessment of beverage intake in 187 countries. PloS One. 2015;10:e0124845
213. Pan A, Hu FB. Effects of carbohydrates on satiety: differences between liquid and solid food. Curr Opin Clin Nutr Metabol Care. 2011;14:385-390
214. Zheng M, Allman-Farinelli M, Heitmann BL, et al. Substitution of sugarsweetened beverages with other beverage alternatives: a review of long-term health outcomes. J Acad Nutr Dietetics. 2015;115:767-779
215. Malik VS, Pan A, Willett WC, et al. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:1084-1102
216. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006;84:274-288
217. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2013;346:e7492
218. Houchins JA, Burgess JR, Campbell WW, et al. Beverage vs. solid fruits and vegetables: effects on energy intake and body weight. Obesity. 2012;20:1844-1850
219. Imamura F, O'Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576
220. Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33:2477-2483
221. Greenwood DC, Threapleton DE, Evans CE, et al. Association between sugarsweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies. Br J Nutr. 2014;112:725-734
222. Te Morenga LA, Howatson AJ, Jones RM, et al. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr. 2014;100:65-79
223. Cheungpasitporn W, Thongprayoon C, Edmonds PJ, et al. Sugar and artificially sweetened soda consumption linked to hypertension: a systematic review and meta-analysis. Clin Exp Hypertens. 2015;29:587-593
224. Jayalath VH, de Souza RJ, Ha V, et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. Am J Clin Nutr. 2015;102:914-921
225. Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol. 2008;19:16-24
226. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev. 2007;65(6 pt 2):S13-S23
227. Wiebe N, Padwal R, Field C, et al. A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes. BMC Med. 2011;9:123
228. Sievenpiper JL, de Souza RJ, Mirrahimi A, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. AnnI Int Med. 2012;156:291-304
229. Chiavaroli L, de Souza RJ, Ha V, et al. Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc. 2015;4:e001700
230. Cozma AI, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care. 2012;35:1611-1620
231. Jayalath VH, Sievenpiper JL, de Souza RJ, et al. Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr. 2014;33:328-339
232. Pereira MA, Odegaard AO. Artificially sweetened beverages-do they influence cardiometabolic risk? Curr Atherosclerosis Reports. 2013;15:375
233. Tucker LA, Tucker JM, Bailey BW, et al. A 4-year prospective study of soft drink consumption and weight gain: the role of calorie intake and physical activity. Am J Health Promotion. 2015;29:262-265
234. de Koning L, Malik VS, Rimm EB, et al. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93:1321-1327
235. Nettleton JA, Lutsey PL, Wang Y, et al. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009;32:688-694
236. Phelan S, Lang W, Jordan D, et al. Use of artificial sweeteners and fat-modified foods in weight loss maintainers and always-normal weight individuals. Int J Obes. 2009;33:1183-1190
237. Pereira MA. Sugar-sweetened and artificially-sweetened beverages in relation to obesity risk. Adv Nutr. 2014;5:797-808
238. de Ruyter JC, Olthof MR, Seidell JC, et al. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med. 2012;367:1397-1406
239. Ebbeling CB, Feldman HA, Chomitz VR, et al. A randomized trial of sugarsweetened beverages and adolescent body weight. New Engl J Med. 2012;367:1407-1416
240. Hu FB. Resolved: there is sufficient scientific evidence that decreasing sugarsweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases. Obes Rev. 2013;14:606-619
241. Kardinaal AF, van Erk MJ, Dutman AE, et al. Quantifying phenotypic flexibility as the response to a high-fat challenge test in different states of metabolic health. FASEB J. 2015;29:4600-4613
242. van Ommen B, van der Greef J, Ordovas JM, et al. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr. 2014;9:423
243. Norat T, Bowman R, Luben R, et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr. 2008;88:392-397
244. Oh SW, Han KH, Han SY, et al. Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat. Medicine (Baltimore). 2015;94:e1650
245. Oh YS, Appel LJ, Galis ZS, et al. National Heart, Lung, and Blood Institute Working Group report on salt in human health and sickness: building on the current scientific evidence. Hypertension. 2016;68:281-288
246. Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829-835
247. Elijovich F, Weinberger MH, Anderson CA, et al. Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension. 2016;68:e7-e46
248. Malaguarnera M, Gargante MP, Russo C, et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial. Am J Gastroenterol. 2010;105:1338-1345
249. Musso G, Gambino R, Cassader M, et al. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52:79-104
250. Guerrerio AL, Colvin RM, Schwartz AK, et al. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012;95:892-900
251. Yu D, Shu XO, Xiang YB, et al. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J Nutr. 2014;144:2034-2040
252. Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res. 2009;46:245-247
253. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev. 2010;62(9-10):967-978
254. Sack RL, Auckley D, Auger RR, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep. 2007;30:1460-1483
255. Gomez-Abellan P, Hernandez-Morante JJ, Lujan JA, et al. Clock genes are implicated in the human metabolic syndrome. Int J Obes (Lond). 2008;32:121-128
256. Gomez-Santos C, Gomez-Abellan P, Madrid JA, et al. Circadian rhythm of clock genes in human adipose explants. Obesity (Silver Spring). 2009;17:1481-1485
257. Garaulet M, Madrid JA. Chronobiology, genetics and metabolic syndrome. Curr Opin Lipidol. 2009;20:127-134
258. Dallmann R, Viola AU, Tarokh L, et al. The human circadian metabolome. Proc Natl Acad Sci U S A. 2012;109:2625-2629
259. Garaulet M, Gomez-Abellan P. Timing of food intake and obesity: a novel association. Physiol Behav. 2014;134:44-50
260. Bandin C, Scheer FA, Luque AJ, et al. Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: A randomized, crossover trial. Int J Obes (Lond). 2015;39:828-833
261. Broussard JL, Ehrmann DA, Van Cauter E, et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157:549-557
262. Rubio-Sastre P, Gomez-Abellan P, Martinez-Nicolas A, et al. Evening physical activity alters wrist temperature circadian rhythmicity. Chronobiol Int. 2014;31:276-282
263. Wolff G, Esser KA. Scheduled exercise phase shifts the circadian clock in skeletal muscle. Med Sci Sports Exerc. 2012;44:1663-1670
264. Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3-9
265. Jacobs DR Jr, Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr. 2009;89:1543S-1548S
266. Perez-Martinez P, Phillips CM, Delgado-Lista J, et al. Nutrigenetics, metabolic syndrome risk and personalized nutrition. Curr Vasc Pharmacol. 2013;11:946-953